ArticleTrials2024

LSDDEP2: study protocol for a randomised, double-dummy, triple-blind, active placebo-controlled, parallel groups trial of LSD microdosing in patients with major depressive disorder.

Dimitri Daldegan-Bueno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.